Primary Peritoneal Carcinoma Not Yet Recruiting Phase 2 Trials for Niraparib (DB11793)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03891576Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer)Treatment